Read about Amazon's entry into the pharmacy business, why a team with a little tension may yield more creative results, and more in our roundup on innovation in health care.
In a move that analysts say could disrupt retail pharmacies and drug distributors, Amazon announced plans to buy PillPack, an online pharmacy. Read more about the deal and its possible impact on the industry from The New York Times.
The Food and Drug Administration approved, for the first time ever, a prescription drug made from marijuana. The drug, Epidiolex, treats two rare forms of epilepsy. According to CBS News, the drug’s approval may “spur more research into a drug that remains illegal under federal law.”
Teams that have all the resources they need and that get along may sound great, but a Harvard Business Review article argues those conditions may not lead to new, innovative ideas. For leaders who want new ideas, the authors suggest: “Fight harmony, inject some tension into your teams and organizations, and embrace a moderate amount of conflict.”
States have been experimenting with new Medicaid ideas under the Trump administration. But research published in Health Affairs found these alternative approaches to Medicaid may not have positive effects, noting the findings “suggest that current Medicaid innovations may lead to unintended consequences for coverage and access.”
STAT News profiles a daring neuroscientist looking into new uses for virtual reality. In one trial, he’s recruiting people with glaucoma to use VR in a way that may keep or restore their vision. In another, he’s using VR to test the body’s response to fear and anxiety.